Hwan-ho Cho

Prof. Hwan-ho Cho

Department of Electronic Engineering, Incheon National University, Incheon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
Hyunjin ParkHyunjin Park
Hyunjin Park
YLYaeji Lim
Yaeji Lim
EKEun Sook Ko
Eun Sook Ko
HCHwan-ho Cho
Hwan-ho Cho
JLJeong Eon Lee
Jeong Eon Lee
KPKo Woon Park
Ko Woon Park
Purpose: To develop a radiomics signature based on preoperative magnetic resonance imaging (MRI) to estimate disease-free survival (DFS) in patients with invasive breast cancer and to establish a radiomics nomogram that incorporates the radiomics signature and MRI and clinicopathological findings. Experimental Design: We identified 294 patients with invasive breast cancer who underwent preoperative MRI. Patients were randomly divided into training (n = 194) and validation (n = 100) sets. A radiomics signature (Rad-score) was generated using an elastic net in the training set, and the cutoff point of the radiomics signature to divide the patients into high- and low-risk groups was determined using receiver operating characteristic curve analysis. Univariate and multivariate Cox proportional hazards model and Kaplan-Meier analysis were used to determine the association of the radiomics signature, MRI findings, and clinicopathological variables with DFS. A radiomics nomogram combining the Rad-score and MRI and clinicopathological findings was constructed to validate the radiomic signatures for individualized DFS estimation. Results: Higher Rad-scores were significantly associated with worse DFS in both the training and validation sets (P = 0.002 and 0.036, respectively). The radiomics nomogram estimated DFS (C-index, 0.76; 95% confidence interval [CI], 0.74-0.77) better than the clinicopathological (C-index, 0.72; 95% CI, 0.70-0.74) or Rad-score-only nomograms (C-index, 0.67; 95% CI, 0.65-0.69). Conclusions: The radiomics signature is an independent biomarker for the estimation of DFS in patients with invasive breast cancer. Combining the radiomics nomogram improved individualized DFS estimation.

22 November 2018 in PeerJ
Verified
Journal Article
Open access
PDF file
HCHwan-ho Cho
Hwan-ho Cho
SLSeung-Hak Lee
Seung-Hak Lee
JKJonghoon Kim
Jonghoon Kim
Hyunjin ParkHyunjin Park
Hyunjin Park
Background: Grading of gliomas is critical information related to prognosis and survival. We aimed to apply a radiomics approach using various machine learning classifiers to determine the glioma grading. Methods: We considered 285 (high grade n = 210, low grade n = 75) cases obtained from the Brain Tumor Segmentation 2017 Challenge. Manual annotations of enhancing tumors, non-enhancing tumors, necrosis, and edema were provided by the database. Each case was multi-modal with T1-weighted, T1-contrast enhanced, T2-weighted, and FLAIR images. A five-fold cross validation was adopted to separate the training and test data. A total of 468 radiomics features were calculated for three types of regions of interest. The minimum redundancy maximum relevance algorithm was used to select features useful for classifying glioma grades in the training cohort. The selected features were used to build three classifier models of logistics, support vector machines, and random forest classifiers. The classification performance of the models was measured in the training cohort using accuracy, sensitivity, specificity, and area under the curve (AUC) of the receiver operating characteristic curve. The trained classifier models were applied to the test cohort. Results: Five significant features were selected for the machine learning classifiers and the three classifiers showed an average AUC of 0.9400 for training cohorts and 0.9030 (logistic regression 0.9010, support vector machine 0.8866, and random forest 0.9213) for test cohorts. Discussion: Glioma grading could be accurately determined using machine learning and feature selection techniques in conjunction with a radiomics approach. The results of our study might contribute to high-throughput computer aided diagnosis system for gliomas.

7 April 2022 in Cancers
Verified
Journal Article
Open access
PDF file
HCHwan-ho Cho
Hwan-ho Cho
HKHaejung Kim
Haejung Kim
SNSang Yu Nam
Sang Yu Nam
JLJeong Eon Lee
Jeong Eon Lee
BHBoo-Kyung Han
Boo-Kyung Han
EKEun Sook Ko
Eun Sook Ko
The purpose of this study was to identify perfusional subregions sharing similar kinetic characteristics from dynamic contrast-enhanced magnetic resonance imaging (MRI) using data-driven clustering, and to evaluate the effect of perfusional heterogeneity based on those subregions on patients’ survival outcomes in various risk models. From two hospitals, 308 and 147 women with invasive breast cancer who underwent preoperative MRI between October 2011 and July 2012 were retrospectively enrolled as development and validation cohorts, respectively. Using the Cox-least absolute shrinkage and selection operator model, a habitat risk score (HRS) was constructed from the radiomics features from the derived habitat map. An HRS-only, clinical, combined habitat, and two conventional radiomics risk models to predict patients’ disease-free survival (DFS) were built. Patients were classified into low-risk or high-risk groups using the median cutoff values of each risk score. Five habitats with distinct perfusion patterns were identified. An HRS was an independent risk factor for predicting worse DFS outcomes in the HRS-only risk model (hazard ratio = 3.274 [95% CI = 1.378–7.782]; p = 0.014) and combined habitat risk model (hazard ratio = 4.128 [95% CI = 1.744–9.769]; p = 0.003) in the validation cohort. In the validation cohort, the combined habitat risk model (hazard ratio = 4.128, p = 0.003, C-index = 0.760) showed the best performance among five different risk models. The quantification of perfusion heterogeneity is a potential approach for predicting prognosis and may facilitate personalized, tailored treatment strategies for breast cancer.

19 September 2018 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
YKYikyung Kim
Yikyung Kim
HCHwan-ho Cho
Hwan-ho Cho
SKSung Tae Kim
Sung Tae Kim
Hyunjin ParkHyunjin Park
Hyunjin Park
DNDohyun Nam
Dohyun Nam
DKDoo-Sik Kong
Doo-Sik Kong

1 July 2017
Verified
Conference Paper
Closed access
HCHwan-ho Cho
Hwan-ho Cho
Hyunjin ParkHyunjin Park
Hyunjin Park
Gliomas are primary brain tumors arising from glial cells. Gliomas can be classified into different histopathologic grades according to World Health Oraganization (WHO) grading system which represents malignancy. In this paper, we present a method to predict the grades of Gliomas using Radiomics imaging features. MICCAI Brain Tumor Segmentation Challenge (BRATs 2015) training data, its segmentation ground truth and the ground truth labels were used for this work. 45 radiomics features based on histogram, shape and gray-level co-occurrence matrix (GLCM) were extracted from each FLAIR, T1, T1-Contrast, T2 image to quantify the property of Gliomas. Significant features among 180 features were selected through L1-norm regularization (LASSO). Based on LASSO coefficient and selected feature values, we computed a LASSO score and gliomas were classified into low-grade glimoa (LGG) or high-grade glimoa (HGG) through logistic regression. Classification result was validated by a 10-fold cross validation. Our method achieved accuracy of 0.8981, sensitivity of 0.8889, specificity of 0.9074, and area under the curve (AUC) = 0.8870.

9 April 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MKMi-ri Kwon
Mi-ri Kwon
JSJung Hee Shin
Jung Hee Shin
Hyunjin ParkHyunjin Park
Hyunjin Park
HCHwan-ho Cho
Hwan-ho Cho
SHSoo Yeon Hahn
Soo Yeon Hahn
KPK.W. Park
K.W. Park
BACKGROUND AND PURPOSE: It is not known how radiomics using ultrasound images contribute to the detection of BRAF mutation. This study aimed to evaluate whether a radiomics study of gray-scale ultrasound can predict the presence or absence of B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutation in papillary thyroid cancer. MATERIALS AND METHODS: The study retrospectively included 96 thyroid nodules that were surgically confirmed papillary thyroid cancers between January 2012 and June 2013. BRAF mutation was positive in 48 nodules and negative in 48 nodules. For analysis, ROIs from the nodules were demarcated manually on both longitudinal and transverse sonographic images. We extracted a total of 86 radiomics features derived from histogram parameters, gray-level co-occurrence matrix, intensity size zone matrix, and shape features. These features were used to build 3 different classifier models, including logistic regression, support vector machine, and random forest using 5-fold cross-validation. The performance including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve, of the different models was evaluated. RESULTS: The incidence of high-suspicion nodules diagnosed on ultrasound was higher in the BRAF mutation–positive group than in the mutation–negative group (P  = .004). The radiomics approach demonstrated that all classification models showed moderate performance for predicting the presence of BRAF mutation in papillary thyroid cancers with an area under the curve value of 0.651, accuracy of 64.3%, sensitivity of 66.8%, and specificity of 61.8%, on average, for the 3 models. CONCLUSIONS: Radiomics study using thyroid sonography is limited in predicting the BRAF mutation status of papillary thyroid carcinoma. Further studies will be needed to validate our results using various diagnostic methods.